0
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Pushing the limit to reach meaningful change: the impact of intensity-driven exercise on clinical outcomes for individuals with Parkinson’s disease. A single-subject design

, , , &
Received 04 Jan 2024, Accepted 01 Aug 2024, Published online: 09 Aug 2024

References

  • Abate KH, Abyu GY, Ahmed MB, et al. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–897. doi: 10.1016/S1474-4422(17)30299-5.
  • Tysnes O-B, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm (Vienna). 2017;124(8):901–905. doi: 10.1007/s00702-017-1686-y.
  • Dorsey ER, Sherer T, Okun MS, et al. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis. 2018;8(s1):S3–S8. doi: 10.3233/JPD-181474.
  • Dorsey ER, Elbaz A, Nichols E, et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939–953. doi: 10.1016/S1474-4422(18)30295-3.
  • Bouça-Machado R, Maetzler W, Ferreira JJ. What is functional mobility applied to Parkinson’s Disease? J Parkinsons Dis. 2018;8(1):121–130. doi: 10.3233/JPD-171233.
  • Blin O, Ferrandez AM, Serratrice G. Quantitative analysis of gait in Parkinson patients: increased variability of stride length. J Neurol Sci. 1990;98(1):91–97. doi: 10.1016/0022-510X(90)90184-O.
  • Morris ME, Iansek R, Matyas TA, et al. The pathogenesis of gait hypokinesia in Parkinson’s disease. Brain. 1994;117 (Pt 5)(5):1169–1181. doi: 10.1093/brain/117.5.1169.
  • Morris M, Iansek R, Matyas T, et al. Abnormalities in the stride length-cadence relation in parkinsonian gait. Mov Disord. 1998;13(1):61–69. doi: 10.1002/mds.870130115.
  • Baker KB, Rochester LP, Nieuwboer AP. The immediate effect of attentional, auditory, and a combined cue strategy on gait during single and dual tasks in Parkinson’s disease. Arch Phys Med Rehabil. 2007;88(12):1593–1600. doi: 10.1016/j.apmr.2007.07.026.
  • Katzel LI, Ivey FM, Sorkin JD, et al. Impaired economy of gait and decreased six-minute walk distance in Parkinson’s disease. Parkinsons Dis. 2012;2012:241754–241756. doi: 10.1155/2012/241754.
  • Falvo MJMS, Earhart G. Six-minute walk distance in persons with Parkinson disease: a hierarchical regression model. Arch Phys Med Rehabil. 2009;90(6):1004–1008. doi: 10.1016/j.apmr.2008.12.018.
  • Giladi N, Simon ES, Springer S, et al. Dual tasking, gait rhythmicity, and Parkinson’s disease: which aspects of gait are attention demanding? Eur J Neurosci. 2005;22(5):1248–1256. doi: 10.1111/j.1460-9568.2005.04298.x.
  • Shearin S, Medley A, Trudelle-Jackson E, et al. Differences in predictors for gait speed and gait endurance in Parkinson’s disease. Gait Posture. 2021;87:49–53. doi: 10.1016/j.gaitpost.2021.04.019.
  • Steffen TM, Hacker TA, Mollinger L. Age- and gender-related test performance in community-dwelling elderly people: six-minute walk test, berg balance scale, timed up & go test, and gait speeds. Phys Ther. 2002;82(2):128–137. doi: 10.1093/ptj/82.2.128.
  • Canning CG, Allen NE, Dean CM, et al. Home-based treadmill training for individuals with Parkinson’s disease: a randomized controlled pilot trial. Clin Rehabil. 2012;26(9):817–826. doi: 10.1177/0269215511432652.
  • Canning CG, Ada L, Johnson JJ, et al. Walking capacity in mild to moderate Parkinson’s disease. Arch Phys Med Rehabil. 2006;87(3):371–375. doi: 10.1016/j.apmr.2005.11.021.
  • Arthur DK, Donelan JM. Dynamic principles of gait and their clinical implications. Phys Ther. 2010;90(2):157–174. doi: 10.2522/ptj.20090125.
  • Osborne JA, Botkin R, Colon-Semenza C, et al. Physical therapist management of parkinson disease: a clinical practice guideline from the american physical therapy association. Phys Ther. 2022;102(4):pzab302. doi:10.1093/ptj/pzab302.
  • Portney LG, Watkins MP. Foundations of clinical research: applications to practice. Upper Saddle River: Prentice Hall Health; 2000. 2nd ed. p. 61–77.
  • Wright Willis A, Evanoff BA, Lian M, et al. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143–151. doi: 10.1159/000275491.
  • Giardini M, Arcolin I, Godi M, et al. Evaluation of Parkinson’s disease progression: changes in spatio-temporal gait variables along the different stages of Hoehn and Yahr scale. Gait & Posture. 2019;74:19–19. doi: 10.1016/j.gaitpost.2019.07.470.
  • Fengler S, Kessler J, Timmermann L, et al. Screening for cognitive impairment in Parkinson’s disease: improving the diagnostic utility of the MoCA through subtest weighting. PLoS One. 2016;11(7):e0159318-e0159318. doi: 10.1371/journal.pone.0159318.
  • Dalrymple-Alford JC, Macaskill MR, Porter RJ, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010;75(19):1717–1725. doi: 10.1212/WNL.0b013e3181fc29c9.
  • Muggeridge DJ, Hickson K, Davies AV, et al. Measurement of heart rate using the polar oh1 and fitbit charge 3 wearable devices in healthy adults during light, moderate, vigorous, and sprint-based exercise: validation study. JMIR Mhealth Uhealth. 2021;9(3):e25313-e25313. doi: 10.2196/25313.
  • Hinde K, White G, Armstrong N. Wearable devices suitable for monitoring twenty four hour heart rate variability in military populations. Sensors (Basel). 2021;21(4):1061. doi: 10.3390/s21041061.
  • Moore JL, Potter K, Blankshain K, et al. A core set of outcome measures for adults with neurologic conditions undergoing rehabilitation: a clinical practice guideline. J Neurol Phys Ther. 2018;42(3):174–220. doi: 10.1097/NPT.0000000000000229.
  • Jonas S, Phillips EM. Medicine ACS. ACSM’s exercise is medicine: a clinician’s guide to exercise prescription. American College of Sports Medicine’s exercise is medicine. Philadelphia (PA): Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009. p. 1–262.
  • Kanegusuku H, Silva-Batista C, Peçanha T, et al. Blunted maximal and submaximal responses to cardiopulmonary exercise tests in patients with Parkinson disease. Arch Phys Med Rehabil. May 2016;97(5):720–725. doi: 10.1016/j.apmr.2015.12.020.
  • Speelman AD, Groothuis JT, van Nimwegen M, et al. Cardiovascular responses during a submaximal exercise test in patients with Parkinson’s disease. J Parkinsons Dis. 2012;2(3):241–247. doi: 10.3233/jpd-2012-012111.
  • Werner WG, DiFrancisco-Donoghue J, Lamberg EM. Cardiovascular response to treadmill testing in Parkinson disease. J Neurol Phys Ther. Jun 2006;30(2):68–73. doi: 10.1097/01.npt.0000282570.78544.00.
  • Penko AL, Barkley JE, Koop MM, et al. Borg scale is valid for ratings of perceived exertion for individuals with Parkinson’s disease. Int J Exerc Sci. 2017;10(1):76–86.
  • Ferguson B. ACSM’s guidelines for exercise testing and prescription 9th Ed. 2014. J Can Chiropr Assoc. 2014;58(3):328.
  • Portney LG, Watkins MP. Foundations of clinical research: applications to practice. 3rd ed. Pearson/Prentice Hall; 2009. p. 725–892.
  • Chetta A, Zanini A, Pisi G, et al. Reference values for the 6-min walk test in healthy subjects 20–50 years old. Respir Med. 2006;100(9):1573–1578. doi: 10.1016/j.rmed.2006.01.001.
  • Scruggs TE, Mastropieri MA. Summarizing single-subject research: issues and Applications. Behav Modif. 1998;22(3):221–242. doi: 10.1177/01454455980223001.
  • Fritz S, Lusardi M. White paper: "walking speed: the sixth vital sign. J Geriatr Phys Ther. 2009;32(2):46–49. doi: 10.1519/00139143-200932020-00002.
  • Steffen T, Seney M. Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with Parkinsonism. Phys Ther. 2008;88(6):733–746. doi: 10.2522/ptj.20070214.
  • Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. Chronic Obstructive Pulmonary Disease. 2005;2(1):125–129. doi: 10.1081/COPD-200050527.
  • Clarke CE, Patel S, Ives N, et al. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB). Health Technol Assess. 2016;20(63):1–96. doi: 10.3310/hta20630.
  • Frenkel‐Toledo S, Giladi N, Peretz C, et al. Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson’s disease. Mov Disord. 2005;20(9):1109–1114. doi: 10.1002/mds.20507.
  • Ridgel AL, Phillips RS, Walter BL, et al. Dynamic high-cadence cycling improves motor symptoms in Parkinson’s disease. Front Neurol. 2015;6:194–194. doi: 10.3389/fneur.2015.00194.
  • Ridgel AL, Vitek JL, Alberts JL. Forced-exercise improves motor function in Parkinson’s disease patients: 1915. Medicine and Science in Sports and Exercise. 2008;40(5):S331. doi: 10.1249/01.mss.0000323328.72398.80.
  • Schenkman M, Moore CG, Kohrt WM, et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol. 2017;75(2):219–226. doi: 10.1001/jamaneurol.2017.3517.
  • Morey MC, Ryan S, Kelly J, et al. The 6th vital sign: a mobile app for population health surveillance of walking speed. Innov Aging. 2017;1(suppl_1):669–669. doi: 10.1093/geroni/igx004.2377.
  • Ridgel AL, Ault DL. High-cadence cycling promotes sustained improvement in bradykinesia, rigidity, and mobility in individuals with mild-moderate Parkinson’s disease. Parkinsons Dis. 2019;2019:4076862–4076867. doi: 10.1155/2019/4076862.
  • Kleim JA, Jones TA. Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. J Speech Lang Hear Res. 2008;51(1):S225–S239. doi: 10.1044/1092-4388(2008/018).
  • Moore JL, Nordvik JE, Erichsen A, et al. Implementation of high-intensity stepping training during inpatient stroke rehabilitation improves functional outcomes. Stroke (1970. 2020;51(2):563–570.) doi: 10.1161/STROKEAHA.119.027450.
  • Ellis T, Boudreau JK, DeAngelis TR, et al. Barriers to exercise in people with Parkinson disease. Phys Ther. 2013;93(5):628–636. doi: 10.2522/ptj.20120279.
  • Cavanaugh JT, Ellis TD, Earhart GM, et al. Toward understanding ambulatory activity decline in Parkinson disease. Phys Ther. 2015;95(8):1142–1150. doi: 10.2522/ptj.20140498.
  • Lord S, Godfrey A, Galna B, et al. Ambulatory activity in incident Parkinson’s: more than meets the eye? J Neurol. 2013;260(12):2964–2972. doi: 10.1007/s00415-013-7037-5.
  • Park J-H, Kim D-H, Park Y-G, et al. Association of Parkinson disease with risk of cardiovascular disease and all-cause mortality: a nationwide, population-based cohort study. Circulation (New York, NY). 2020;141(14):1205–1207. doi: 10.1161/CIRCULATIONAHA.119.044948.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.